PetMed Express Files 8-K on Director Changes & Compensation

Ticker: PETS · Form: 8-K · Filed: 2025-10-21T00:00:00.000Z

Sentiment: neutral

Topics: director-change, executive-compensation, regulation-fd

Related Tickers: PETS

TL;DR

PETS 8-K: Director changes and compensation updates filed. Watch for details.

AI Summary

On October 19, 2025, PetMed Express, Inc. filed an 8-K report detailing changes in its board of directors and executive compensation arrangements. The filing also includes information regarding financial statements and exhibits, and a Regulation FD disclosure. Specific details on the individuals involved or the exact nature of the compensation changes were not provided in this excerpt.

Why It Matters

This filing signals potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and compensation can indicate internal shifts or strategic realignments that may carry inherent risks.

Key Numbers

Key Players & Entities

FAQ

What specific changes were made to the board of directors?

The filing indicates a departure of directors or election of directors, but the specific names and details of these changes are not provided in the excerpt.

What are the details of the new compensatory arrangements?

The filing mentions compensatory arrangements of certain officers, but the specific details, amounts, or individuals involved are not included in this excerpt.

What is the primary reason for this 8-K filing?

The primary reasons for this 8-K filing are the departure of directors or certain officers, election of directors, appointment of certain officers, compensatory arrangements of certain officers, Regulation FD Disclosure, and Financial Statements and Exhibits.

When was the earliest event reported in this filing?

The earliest event reported in this filing occurred on October 19, 2025.

What is PetMed Express, Inc.'s principal executive office address?

PetMed Express, Inc.'s principal executive office is located at 420 South Congress Avenue, Delray Beach, Florida 33445.

From the Filing

0001040130-25-000077.txt : 20251021 0001040130-25-000077.hdr.sgml : 20251021 20251021162221 ACCESSION NUMBER: 0001040130-25-000077 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20251019 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20251021 DATE AS OF CHANGE: 20251021 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PETMED EXPRESS INC CENTRAL INDEX KEY: 0001040130 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] ORGANIZATION NAME: 07 Trade & Services EIN: 650680967 STATE OF INCORPORATION: FL FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-42429 FILM NUMBER: 251407332 BUSINESS ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 BUSINESS PHONE: (561) 426-4444 MAIL ADDRESS: STREET 1: 420 SOUTH CONGRESS AVENUE CITY: DELRAY BEACH STATE: FL ZIP: 33445 8-K 1 pets-20251019.htm 8-K pets-20251019 0001040130 FALSE 0001040130 2025-10-19 2025-10-19 0001040130 us-gaap:CommonStockMember 2025-10-19 2025-10-19 0001040130 us-gaap:PreferredStockMember 2025-10-19 2025-10-19 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  October 19, 2025 PetMed Express, Inc. (Exact name of registrant as specified in its charter) Florida 000-28827 65-0680967 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 420 South Congress Avenue , Delray Beach , Florida 33445 (Address of principal executive offices) (Zip Code) ( 561 )  526-4444 (Registrant’s telephone number, including area code) Not Applicable (Former name or former address, if changed since last report) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, par value $.001 per share PETS NASDAQ Preferred Stock Purchase Rights N/A NASDAQ Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company  o If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. (d) Appointment of Director On October 19, 2025, the Board of Directors (the “Board”) of PetMed Express, Inc. (the “Company”), appointed James LaCamp to serve as a director of the Company effective immediately. Mr. LaCamp will hold this position until the 2025 annual meeting of the Company’s stockholders or until his successor is elected and qualified, subject to his ea

View on Read The Filing